Inflammatory Breast Cancer
📧 Sign up to get email alerts when something new happens for Inflammatory Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer [Phase 2]
Phase 2 trial evaluating ipilimumab and nivolumab in recurrent stage IV HER2-negative inflammatory breast cancer; study terminated with resu…
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: MUC1 Vaccine for Triple-negative Breast Cancer [EARLY_Phase 1]
An early-phase Phase 1 trial evaluating a MUC1 vaccine for breast cancer has completed its evaluation. The study targets inflammatory breast…
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer [Phase 2]
A Phase 2 study of Avastin (bevacizumab) in patients with inflammatory breast cancer or locally advanced breast cancer has completed, with r…
-
CLINICAL_TRIALS trial_result · 2017-09-29Clinical Trial Update: Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of romidepsin plus Abraxane in HER2-negative inflammatory and metastatic breast cancer was terminated, with results posted…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial of bevacizumab for inflammatory breast cancer and locally advanced breast cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis
This completed NCI-sponsored clinical trial investigates tumor markers and factors associated with angiogenesis in inflammatory breast cance…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia
This entry reports the completion of a pilot clinical trial studying inflammatory breast cancer in Egypt and Tunisia.
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer [Phase 2]
A Phase 2 trial evaluating nab-paclitaxel with doxorubicin, cyclophosphamide, and pegfilgrastim, with or without bevacizumab, in women with …
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer [Phase 2]
A Phase 2 study evaluating lapatinib in combination with paclitaxel for newly diagnosed inflammatory breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy and peripheral blood stem cell transplant followed by Aldesleukin and Sargramostim in inflammatory Sta…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer [Phase 2]
Phase 2 trial evaluating a neoadjuvant regimen of sunitinib, paclitaxel, doxorubicin, and cyclophosphamide in stage IIB-IIIC breast cancer; …
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: TKI258 for Metastatic Inflammatory Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update for TKI258 in metastatic inflammatory breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer [Phase 2]
A Phase 2 trial evaluating adding cisplatin to neoadjuvant therapy for locally advanced breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer [Phase 2]
A Phase 2 trial of afatinib (BIBW2992) in HER2-overexpressing inflammatory breast cancer has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer. [Phase 2]
A Phase 2 study evaluating the combination of Avastin (bevacizumab) and trastuzumab (Herceptin) in patients with primary inflammatory HER2-p…
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating lapatinib in patients with relapsed or refractory inflammatory breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating neoadjuvant tipifarnib with docetaxel and capecitabine in adults with locally advanced or metastatic bre…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Phase II Neoadjuvant in Inflammatory Breast Cancer [Phase 2]
Phase II neoadjuvant trial in inflammatory breast cancer was terminated, with results posted on 2014-11-05.
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer [Phase 2]
A Phase 2 trial evaluating the combination of trastuzumab, docetaxel, and carboplatin in women with stage II/III or inflammatory breast canc…
-
CLINICAL_TRIALS trial_result · 2013-10-24Clinical Trial Update: Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer [Phase 3]
Phase 3 trial assessing p53 biomarker analysis and sequence of combination chemotherapy followed by radiation therapy and surgery for women …
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer [Phase 1]
This Phase 1 trial assesses the efficacy and safety of bevacizumab given in the neoadjuvant setting for inflammatory breast cancer.
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating the three-drug combination of tipifarnib, doxorubicin, and cyclophosphamide in women with locally advanced breast c…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer [Phase 3]
A Phase 3 trial comparing a standard doxorubicin/cyclophosphamide/paclitaxel regimen with or without filgrastim in women with inflammatory o…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer [Phase 3]
A Phase 3 trial evaluating combination chemotherapy with surgery and radiation, with or without Dexrazoxane and Trastuzumab, for stage III/I…
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer [Phase 2]
A phase 2 clinical trial compared pazopanib plus lapatinib versus lapatinib alone in inflammatory breast cancer; results were posted in July…